Pittsburgh Seeks Breast Cancer Patients for Study on Coping

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 8
Volume 7
Issue 8

PITTSBURGH--The University of Pittsburgh Cancer Institute’s Division of Behavioral Medicine and Oncology is seeking young women with breast cancer for a research study on helping families cope with cancer.

PITTSBURGH--The University of Pittsburgh Cancer Institute’s Division of Behavioral Medicine and Oncology is seeking young women with breast cancer for a research study on helping families cope with cancer.

The women will participate in educational and support groups for couples to discuss coping with a chronic illness, stress management skills, family communication, and parenting concerns. These groups, led by an oncology nurse and a health psychologist, will meet 1½ hours once a week for 8 weeks.

In addition, groups for children ages 3 to 12 may be available and would take place at the same time as the parent groups. The children will receive support and develop their skills for coping with feelings and managing stress.

To be eligible for this study, women must be premenopausal and have been diagnosed with breast cancer in the past 5 years, have a partner, and have children between the ages of 3 and 12. For more information, call 412-624-4806.

Recent Videos
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.
Reshma L. Mahtani, DO, describes how updates from the DESTINY-Breast09, ASCENT-04, and VERITAC-2 trials may shift practices in the breast cancer field.
Multidisciplinary care can help ensure that treatment planning does not deviate from established guidelines for inflammatory breast cancer management.
Photographic and written documentation can help providers recognize inflammatory breast cancer symptoms across diverse populations.
The use of guideline-concordant care in breast cancer appears to be more common in White populations than Black populations.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content